ICD-9 Codes
|
011.00-011.96 | Tuberculosis of lung infiltrative confirmation unspecified – unspecified pulmonary tuberculosis tubercle bacilli not found by bacteriological histological examination but tuberculosis confirmed by other methods. |
020.3-020.5 | Primary pneumonic plague – pneumonic plague unspecified |
021.2 | Pulmonary tularemia |
039.1 | Pulmonary actinomycotic infection |
052.1 | Varicella (hemorrhagic pneumonitis) |
073.0 | Ornithosis with pneumonia |
079.82 | SARS-associated coronavirus infection |
130.4 | Pneumonitis due to toxoplasmosis |
135 | Sarcoidosis |
136.3 | Pneumocystosis |
162.0-162.9 | Malignant neoplasm of trachea – malignant neoplasm of bronchus and lung unspecified |
163.0 – 163.9 | Malignant neoplasm of pleura |
197.0 | Secondary malignant neoplasm of lung |
277.00 | Cystic fibrosis without meconium ileus |
277.01 | Cystic fibrosis with meconium ileus |
277.02 | Cystic fibrosis with pulmonary manifestations |
277.03 | Cystic fibrosis with gastrointestinal manifestations |
277.09 | Cystic fibrosis with other manifestations |
289.0 | Polycythemia secondary |
293.0 | Delirium due to conditions classified elsewhere |
327.09 | Other organic insomnia |
327.21 | Primary central sleep apnea |
327.23 | Obstructive sleep apnea (adult) (pediatric) |
327.29 | Other organic sleep apnea |
335.20 | Amyotrophic lateral sclerosis |
357.0 | Acute infective polyneuritis |
358.00 | Myasthenia gravis without (acute) exacerbation |
358.01 | Myasthenia gravis with (acute) exacerbation |
391.8 | Other acute pneumatic heart disease |
392.0 | Rheumatic chorea with heart involvement |
398.91 | Rheumatic heart failure (congestive) |
402.01 | Malignant hypertensive heart disease with heart failure |
402.11 | Benign hypertensive heart disease with heart failure |
402.91 | Unspecified hypertensive heart disease with heart failure |
404.91 | Hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease Stage I through Stage IV, or unspecified |
404.93 | Hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease Stage V or end stage renal disease |
415.0 | Acute cor pulmonale |
415.11 | Iatrogenic pulmonary embolism and infarction |
415.12 | Septic pulmonary embolism |
416.0 | Primary pulmonary hypertension |
416.9 | Chronic pulmonary heart disease unspecified |
427.89 | Other specified cardiac dysrhythmias |
428.0 | Congestive heart failure unspecified |
428.1 | Left heart failure |
428.20-428.23 | Unspecified systolic heart failure – acute on chronic systolic heart failure |
428.30-428.33 | Unspecified diastolic heart failure – acute on chronic diastolic heart failure |
428.40-428.43 | Unspecified combined systolic and diastolic heart failure – acute on chronic combined systolic and diastolic heart failure |
428.9 | Heart failure unspecified |
464.51 | Supraglottitis unspecified with obstruction |
466.0-466.19 | Acute bronchitis – acute bronciolitis due to other infectious organisms |
478.30-478.34 | Unspecified paralysis of vocal cords – complete bilateral paralysis of vocal cords |
478.6 | Edema of larynx |
478.70 | Unspecified disease of larynx |
478.71 | Cellulitis and perichondritis of larynx |
478.74 | Stenosis of larynx |
478.75 | Laryngeal spasm |
478.79 | Other diseases of larynx |
478.8 | Upper respiratory tract hypersensitivity reaction site unspecified |
480.0 | Pneumonia due to adenovirus |
480.1 | Pneumonia due to respiratory syncytial virus |
480.2 | Pneumonia due to parainfluenza virus |
480.3 | Pneumonia due SARS-associated coronavirus |
480.8 | Pneumonia due to other virus not elsewhere classified |
480.9 | Viral pneumonia unspecified |
481 | Pneumococcal pneumonia (streptococcus pneumoniae pneumonia) |
482.1 | Pneumonia due to pseudomonas |
482.30-482.39 | Pneumonia due to streptococcus unspecified – pneumonia due to other streptococcus |
482.40 | Pneumonia due to staphylococcus unspecified |
482.41 | Pneumonia due to staphylococcus aureus |
482.49 | Other staphylococcus pneumonia |
482.81-482.89 | Pneumonia due to anaerobes – pneumonia due to other specified bacteria |
483.0-483.8 | Pneumonia due to mycoplasma pneumoniae – pneumonia due to other specified organism |
484.1-484.8 | Pneumonia in cytomegalic inclusion disease – pneumonia in other infectious diseases classified elsewhere. |
485 | Bronchopneumonia organism unspecified |
486 | Pneumonia organism unspecified |
487.0 | Influenza with pneumonia |
487.1 | Influenza with other respiratory manifestations |
488 | Influenza due to identified avian influenza virus |
490 | Bronchitis not specified as acute or chronic |
491.1 | Mucopurulent chronic bronchitis |
491.20-491.21 | Obstructive chronic bronchitis without exacerbation – obstructive chronic bronchitis with (acute) exacerbation |
491.8 | Other chronic bronchitis |
491.9 | Unspecified chronic bronchitis |
492.0 | Emphysematous bleb |
492.8 | Other emphysema |
493.00-493.01 | Extrinsic asthma unspecified – extrinsic asthma with status asthmaticus |
493.10-493.11 | Intrinsic asthma unspecified – intrinsic asthma with status asthmaticus |
493.20-493.21 | Chronic obstructive asthma unspecified – chronic obstructive asthma with status asthmaticus |
493.81 | Exercise-induced bronchospasm |
493.82 | Cough variant asthma |
493.90-493.91 | Asthma unspecified – asthma unspecified type with status asthmaticus |
494.0-494.1 | Bronchiectasis without acute exacerbation – bronchiectasis with acute exacerbation |
495.0-495.9 | Farmers’ lung – unspecified allergic alveolitis and pneumonitis |
496 | Chronic airway obstruction not elsewhere classified |
500 | Coal workers’ pneumoconiosis |
501 | Asbestosis |
502 | Pneumoconiosis due to other silica or silicates |
503 | Pneumoconiosis due to other inorganic dust |
504 | Pneumonopathy due to inhalation of other dust |
505 | Pneumoconiosis unspecified |
506.0-506.9 | Bronchitis and pneumonitis due to fumes and vapors – unspecified respiratory conditions due to fumes and vapors |
507.0-507.8 | Pneumonitis due to inhalation of food or vomitus – pneumonitis due to other solids and liquids |
508.0-508.9 | Acute pulmonary manifestations due to radiation – respiratory conditions due to unspecified external agent |
510.0-510.9 | Empyema with fistula – empyema without fistula |
511.0-511.9 | Pleurisy without effusion or current tuberculosis – unspecified pleural effusion |
512.0-512.8 | Spontaneous tension pneumothorax – other spontaneous pneumothorax |
513.0-513.1 | Abscess of lung – abscess of mediastinum |
514 | Pulmonary congestion and hypostasis |
515 | Postinflammatory pulmonary fibrosis |
516.0-516.9 | Pulmonary alveolar proteinosis – unspecified alveolar and parietoalveolar pneumonopathy |
517.1 | Rheumatic pneumonia |
517.2 | Lung involvement in systemic sclerosis |
517.3 | Acute chest syndrome |
519.4 | Disorders of diaphragm |
710.1 | Systemic sclerosis |
714.81 | Rheumatoid lung |
748.61 | Congenital bronchiectasis |
780.01-780.09 | Coma – alteration of consciousness other |
780.39 | Other convulsions |
780.51 | Insomnia with sleep apnea, unspecified |
780.53 | Hypersomnia with sleep apnea, unspecified |
780.57 | Unspecified sleep apnea |
782.5 | Cyanosis |
785.0 | Tachycardia unspecified |
785.50 | Shock unspecified |
785.51 | Cardiogenic shock |
785.52 | Septic shock |
785.59 | Other shock without trauma |
786.00-786.09 | Respiratory abnormality unspecified – respiratory abnormality other |
786.3 | Hemoptysis |
786.50-786.59 | Unspecified chest pain – other chest pain |
786.6 | Swelling mass or lump in chest |
793.1 | Nonspecific abnormal findings on radiological and other examination of lung field |
799.01-799.1 | Asphyxia - respiratory |
807.4 | Flail chest |
958.7 | Traumatic subcutaneous emphysema |
987.9 | Toxic effect of unspecified gas fume or vapor |
997.3 | Respiratory complications not elsewhere classified |
998.81 | Emphysema (subcutaneous) (surgical) resulting from procedure |
V01.82 | Exposure to SARS-associated coronavirus |
V42.6 | Lung replaced by transplant |
V58.69 | Long-term (current) use of other medications |
V67.2 | Follow-up examination following chemotherapy |
ENG
中文
